(Q34795075)

4 August 2017

In vivo bradykinin B2 receptor activation reduces renal fibrosis. (English)

1 reference

4 August 2017

Michael Bader

8

0 references

author name string

Joost P Schanstra

1

1 reference

4 August 2017

Eric Neau

2

1 reference

4 August 2017

Pascale Drogoz

3

1 reference

4 August 2017

Miguel A Arevalo Gomez

4

1 reference

4 August 2017

José Miguel Lopez Novoa

5

1 reference

4 August 2017

Denis Calise

6

1 reference

4 August 2017

Christiane Pecher

7

1 reference

4 August 2017

Jean-Pierre Girolami

9

1 reference

4 August 2017

Jean-Loup Bascands

10

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Journal of Clinical Investigation

4 August 2017

1 reference

4 August 2017

110

1 reference

4 August 2017

3

1 reference

4 August 2017

371-379

1 reference

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Therapeutic approaches in obstructive uropathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Theodore Cooper Memorial Lecture. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

The progression of renal disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Tubulointerstitial changes as a major determinant in the progression of renal damage

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151090

Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis

9 December 2018

1 reference

12 December 2020

Bradykinin stimulates tissue plasminogen activator release in human vasculature

1 reference

12 December 2020

Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity

1 reference

12 December 2020

Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism

1 reference

12 December 2020

Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK

1 reference

12 December 2020

Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice

1 reference

12 December 2020

Tissue plasminogen activator release in vivo in response to vasoactive agents

1 reference

12 December 2020

Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney

1 reference

12 December 2020

Bradykinin receptor antagonists

1 reference

12 December 2020

Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides

1 reference

12 December 2020

Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney

1 reference

12 December 2020

Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction

1 reference

12 December 2020

Are angiotensin II receptor blockers superior to angiotensin converting enzyme inhibitors with regard to their renoprotective effect?

1 reference

12 December 2020

Obstructive nephropathy

1 reference

12 December 2020

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI0215493

1 reference

release_wcofxp7a7zfsxetckdaycaxlpe

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wcofxp7a7zfsxetckdaycaxlpe

24 November 2022

mapped directly with Wikidata item

PMCID

151090

1 reference

4 August 2017

1 reference